TERESA MONEY: Open Payments
NPI 1780120097 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,259 in 52 payments from 12 companies in 2025. Trend: 2023 $292 · 2024 $305 · 2025 $1,259
Food & beverage: $1,259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $380 |
| AstraZeneca Pharmaceuticals LP | 4 | $223 |
| Axsome Therapeutics, Inc. | 7 | $195 |
| Braeburn Inc. | 6 | $119 |
| UCB, Inc. | 1 | $110 |
| Vanda Pharmaceuticals Inc. | 3 | $69 |
| Amgen Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Abbott Laboratories | 1 | $21 |
Products named: VRAYLAR, Sunosi, BRIXADI, Bimzelx, BREZTRI, HETLIOZ, EVENITY, VIVITROL.
Industry payments across AR — which companies pay providers there.
